01816nas a2200205   4500008004100000022001400041245007800055210006900133260000800202490000800210520111600218653003501334653001901369653001501388653003501403100001901438700001901457700002201476856011201498       2024                        eng d  a0048-969700aBacteriophages: status quo and emerging trends toward one health approach0 aBacteriophages status quo and emerging trends toward one health   cJAN0 v9083 a<p>The alarming rise in antimicrobial resistance (AMR) among the drug-resistant pathogens has been attributed to the ESKAPEE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, Enterobacter sp., and Escherichia coli). Recently, these AMR microbes have become difficult to treat, as they have rendered the existing therapeutics ineffective. Thus, there is an urgent need for effective alternatives to lessen or eliminate the current infections and limit the spread of emerging diseases under the ``One Health'' framework. Bacteriophages (phages) are naturally occurring biological resources with extraordinary potential for biomedical, agriculture/food safety, environmental protection, and energy production. Specific unique properties of phages, such as their bactericidal activity, host specificity, potency, and biocompatibility, make them desirable candidates in therapeutics. The recent biotechnological advancement has broadened the repertoire of phage applications in nanoscience, material science, physical chemistry, and soft</p>
10aAntimicrobial resistance (AMR)10aBacteriophages10aOne-health10aTherapeutics commercialization1 aSamson, Rachel1 aDharne, Mahesh1 aKhairnar, Krishna  uhttps://library.ncl.res.in/content/bacteriophages-status-quo-and-emerging-trends-toward-one-health-approach